Published in J Biol Chem on November 15, 1990
Detecting cAMP-induced Epac activation by fluorescence resonance energy transfer: Epac as a novel cAMP indicator. EMBO Rep (2004) 2.98
Cellular mechanisms underlying prostaglandin-induced transient cAMP signals near the plasma membrane of HEK-293 cells. Am J Physiol Cell Physiol (2006) 1.17
Roles of GRK and PDE4 activities in the regulation of beta2 adrenergic signaling. J Gen Physiol (2008) 1.08
Mechanisms associated with cGMP binding and activation of cGMP-dependent protein kinase. Proc Natl Acad Sci U S A (2003) 1.01
Fluorescence fluctuations of quantum-dot sensors capture intracellular protein interaction dynamics. Nat Methods (2010) 0.84
Allosteric communication between cAMP binding sites in the RI subunit of protein kinase A revealed by NMR. J Biol Chem (2010) 0.83
T cell receptor induced intracellular redistribution of type I protein kinase A. Immunology (2004) 0.80
Differential expression of cAMP-kinase subunits is correlated with growth in rat mammary carcinomas and uterus. Br J Cancer (1992) 0.77
The Chemical Induction of Genetic Changes in Fungi. Proc Natl Acad Sci U S A (1939) 2.82
Escherichia coli mutants deficient in the aspartate and aromatic amino acid aminotransferases. J Bacteriol (1977) 2.56
Mutations causing charge alterations in regulatory subunits of the cAMP-dependent protein kinase of cultured S49 lymphoma cells. Cell (1977) 2.20
Injected cytochrome c induces apoptosis. Nature (1998) 2.05
In vitro repression of RNA synthesis by purified lambda phage repressor. Nat New Biol (1971) 1.82
Inhibition of synthesis of phiX174 DNA in a mutant host thermosensitive for DNA synthesis. J Mol Biol (1968) 1.79
Fine mapping of 28S rRNA sites specifically cleaved in cells undergoing apoptosis. Mol Cell Biol (1995) 1.78
Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis (1997) 1.78
A "Frenching" Response of Tobacco Seedlings to Isoleucine. Science (1946) 1.74
Iron and Copper Enzymes in Leaf Lamina of Tobacco When Deficient in Micronutrients or Grown on Calcareous and Organic Soils. Plant Physiol (1953) 1.57
Probing the cyclic nucleotide binding sites of cAMP-dependent protein kinases I and II with analogs of adenosine 3',5'-cyclic phosphorothioates. J Biol Chem (1990) 1.57
The protein phosphatase inhibitor okadaic acid induces morphological changes typical of apoptosis in mammalian cells. Exp Cell Res (1991) 1.55
"Superinduction" of tyrosine aminotransferase by actinomycin D: a reevaluation. Cell (1975) 1.50
Two-dimensional gel analysis of cyclic AMP effects in cultured S49 mouse lymphoma cells: protein modifications, inductions and repressions. Cell (1979) 1.44
[Prostate-specific membrane antigen. A new sensitive molecular indicator in metastasizing prostatic cancer]. Tidsskr Nor Laegeforen (1995) 1.39
Cyclic AMP-dependent protein kinase type I mediates the inhibitory effects of 3',5'-cyclic adenosine monophosphate on cell replication in human T lymphocytes. J Biol Chem (1992) 1.37
Novel (Rp)-cAMPS analogs as tools for inhibition of cAMP-kinase in cell culture. Basal cAMP-kinase activity modulates interleukin-1 beta action. J Biol Chem (1995) 1.36
Kinase-negative mutants of S49 mouse lymphoma cells carry a trans-dominant mutation affecting expression of cAMP-dependent protein kinase. Cell (1978) 1.27
Simplified method for selective amplification and direct sequencing of cDNAs. Biotechniques (1989) 1.25
Turnover of regulatory subunit of cyclic AMP-dependent protein kinase in S49 mouse lymphoma cells. Regulation by catalytic subunit and analogs of cyclic AMP. J Biol Chem (1981) 1.15
Quantitative analysis of electrophoretograms: a mathematical approach to super-resolution. Anal Biochem (1981) 1.13
Programmed cell death (apoptosis) is induced rapidly and with positive cooperativity by activation of cyclic adenosine monophosphate-kinase I in a myeloid leukemia cell line. J Cell Physiol (1991) 1.12
Physiological phosphorylation of protein kinase A at Thr-197 is by a protein kinase A kinase. Mol Cell Biol (1998) 1.10
Comparison of the two classes of binding sites (A and B) of type I and type II cyclic-AMP-dependent protein kinases by using cyclic nucleotide analogs. Eur J Biochem (1989) 1.09
Suppression of Axillary Growth in Decapitated Tobacco Plants by Chemicals. Science (1947) 1.07
Actin nascent chains are substrates for cyclic AMP-dependent phosphorylation in vivo. Proc Natl Acad Sci U S A (1980) 1.07
Studies of cGMP analog specificity and function of the two intrasubunit binding sites of cGMP-dependent protein kinase. J Biol Chem (1986) 1.06
Ultrarapid caspase-3 dependent apoptosis induction by serine/threonine phosphatase inhibitors. Cell Death Differ (1999) 1.06
Studies on the phosphorylation and synthesis of type I regulatory subunit of cyclic AMP-dependent protein kinase in intact S49 mouse lymphoma cells. J Biol Chem (1981) 1.05
Activation of protein kinase isozymes by cyclic nucleotide analogs used singly or in combination. Principles for optimizing the isozyme specificity of analog combinations. Eur J Biochem (1985) 1.05
Multiple apoptotic death types triggered through activation of separate pathways by cAMP and inhibitors of protein phosphatases in one (IPC leukemia) cell line. J Cell Sci (1994) 1.04
Protein phosphorylation in apoptosis. Biochim Biophys Acta (1995) 1.04
Kinetics of steroid induction and deinduction of tyrosine aminotransferase synthesis in cultured hepatoma cells. Proc Natl Acad Sci U S A (1975) 1.03
Relationship of cyclic AMP binding capacity and estrogen receptor to hormone sensitivity in human breast cancer. Breast Cancer Res Treat (1983) 1.02
Selective cleavage of 28S rRNA variable regions V3 and V13 in myeloid leukemia cell apoptosis. FEBS Lett (1993) 1.02
Studies of two different intrachain cGMP-binding sites of cGMP-dependent protein kinase. J Biol Chem (1983) 1.02
Selective modulation of protein kinase isozymes by the site-selective analog 8-chloroadenosine 3',5'-cyclic monophosphate provides a biological means for control of human colon cancer cell growth. Proc Natl Acad Sci U S A (1988) 1.02
Some aspects of the phosphorylation of phenylalanine 4-monooxygenase by a calcium-dependent and calmodulin-dependent protein kinase. Eur J Biochem (1984) 0.98
Low-frequency mutation of Ha-ras and Ki-ras oncogenes in transitional cell carcinoma of the bladder. Anticancer Res (1998) 0.97
The separate estimation of cAMP intracellularly bound to the regulatory subunits of protein kinase I and II in glucagon-stimulated rat hepatocytes. J Biol Chem (1985) 0.96
Cleaved intracellular plasminogen activator inhibitor 2 in human myeloleukaemia cells is a marker of apoptosis. Br J Cancer (1994) 0.95
Characterization of the interchain and intrachain interactions between the binding sites of the free regulatory moiety of protein kinase I. J Biol Chem (1984) 0.94
Microinjected catalytic subunit of cAMP-dependent protein kinase induces apoptosis in myeloid leukemia (IPC-81) cells. Exp Cell Res (1993) 0.92
The effect of ligands of phenylalanine 4-monooxygenase on the cAMP-dependent phosphorylation of the enzyme. J Biol Chem (1984) 0.91
Okadaic acid, cAMP, and selected nutrients inhibit hepatocyte proliferation at different stages in G1: modulation of the cAMP effect by phosphatase inhibitors and nutrients. J Cell Physiol (1995) 0.91
Frequent mutations of the p53 gene in cutaneous melanoma of the nodular type. Int J Cancer (1998) 0.91
CaM-kinaseII-dependent commitment to microcystin-induced apoptosis is coupled to cell budding, but not to shrinkage or chromatin hypercondensation. Cell Death Differ (2005) 0.90
8-Chloro-cAMP induces apoptotic cell death in a human mammary carcinoma cell (MCF-7) line. Br J Cancer (1995) 0.90
Radiolabeling and detection methods for studying metabolism of regulatory subunit of cAMP-dependent protein kinase I in intact cultured cells. Methods Enzymol (1983) 0.90
8-Substituted cAMP analogues reveal marked differences in adaptability, hydrogen bonding, and charge accommodation between homologous binding sites (AI/AII and BI/BII) in cAMP kinase I and II. Biochemistry (2000) 0.90
Antiapoptotic effect of heterozygously expressed mutant RI (Ala336-->Asp) subunit of cAMP kinase I in a rat leukemia cell line. J Biol Chem (1993) 0.90
Sensitive detection of apoptogenic toxins in suspension cultures of rat and salmon hepatocytes. Toxicon (1998) 0.90
Fas/APO-1(CD95)-induced apoptosis of primary hepatocytes is inhibited by cAMP. Biochem Biophys Res Commun (1997) 0.90
Comparison of some physicochemical and kinetic properties of S-adenosylhomocysteine hydrolase from bovine liver, bovine adrenal cortex and mouse liver. Biochim Biophys Acta (1982) 0.90
Mutations that alter the charge of type I regulatory subunit and modify activation properties of cyclic AMP-dependent protein kinase from S49 mouse lymphoma cells. J Biol Chem (1991) 0.89
Cyclic AMP can promote APL progression and protect myeloid leukemia cells against anthracycline-induced apoptosis. Cell Death Dis (2013) 0.89
Mutations that prevent cyclic nucleotide binding to binding sites A or B of type I cyclic AMP-dependent protein kinase. J Biol Chem (1988) 0.89
Molecular basis for the 3',5'-cyclic adenosine monophosphate resistance of Kin mutant Y1 adrenocortical tumor cells. Mol Endocrinol (1993) 0.87
Cyclic adenosine monophosphate (cAMP) analogs 8-Cl- and 8-NH2-cAMP induce cell death independently of cAMP kinase-mediated inhibition of the G1/S transition in mammary carcinoma cells (MCF-7). Endocrinology (1995) 0.87
Essentiality of Calcium in the Nutrition of Fungi. Science (1948) 0.87
The expression of cAMP-dependent protein kinase subunits is differentially regulated during liver regeneration. J Biol Chem (1989) 0.87
The ability to cleave 28S ribosomal RNA during apoptosis is a cell-type dependent trait unrelated to DNA fragmentation. Cell Death Differ (1997) 0.87
Mapping of the two intrachain cyclic nucleotide binding sites of adenosine cyclic 3',5'-phosphate dependent protein kinase I. Biochemistry (1983) 0.86
Phenylalanine positively modulates the cAMP-dependent phosphorylation and negatively modulates the vasopressin-induced and okadaic-acid-induced phosphorylation of phenylalanine 4-monooxygenase in intact rat hepatocytes. Eur J Biochem (1992) 0.86
Cyclic nucleotides modulate the release of [3H] adenosine cyclic 3',5'-phosphate bound to the regulatory moiety of protein kinase I by the catalytic subunit of the kinase. Biochemistry (1983) 0.86
Protein kinase II has two distinct binding sites for cyclic AMP, only one of which is detectable by the conventional membrane-filtration method. FEBS Lett (1980) 0.86
cAMP inhibits translation by inducing Ca2+/calmodulin-independent elongation factor 2 kinase activity in IPC-81 cells. FEBS Lett (1999) 0.86
Evidence that rabbit muscle protein kinase has two kinetically distinct binding sites for adenosine 3' ; 5'-cyclic monophosphate. Biochem Biophys Res Commun (1978) 0.86
The kinetics of the interaction between cyclic AMP and the regulatory moiety of protein kinase II. Evidence for interaction between the binding sites for cyclic AMP. FEBS Lett (1981) 0.86
Studies on the interactions between the cyclic nucleotide-binding sites of cGMP-dependent protein kinase. J Biol Chem (1987) 0.85
Divergence towards a dead end? Cleavage of the divergent domains of ribosomal RNA in apoptosis. Experientia (1996) 0.85
Binding proteins for cyclic AMP in mammalian tissues. Int J Biochem (1981) 0.85
Arg-242 is necessary for allosteric coupling of cyclic AMP-binding sites A and B of RI subunit of cyclic AMP-dependent protein kinase. J Biol Chem (1994) 0.85
Hotspots for spontaneous and mutagen-induced lesions in regulatory subunit of cyclic AMP-dependent protein kinase in S49 mouse lymphoma cells. Somat Cell Mol Genet (1985) 0.84
Cyclic AMP induces IPC leukemia cell apoptosis via CRE-and CDK-dependent Bim transcription. Cell Death Dis (2011) 0.84
A variant of S49 mouse lymphoma cells with enhanced secretion of cyclic AMP. J Cell Physiol (1979) 0.84
Pathways for degradation of the catalytic subunit of cAMP-dependent protein kinase differ in wild-type and kinase-negative S49 mouse lymphoma cells. J Biol Chem (1996) 0.83
Hepatocyte DNA replication is abolished by inhibitors selecting protein phosphatase 2A rather than phosphatase 1. Exp Cell Res (1993) 0.83
Analysis of the dominance of mutations in cAMP-binding sites of murine type I cAMP-dependent protein kinase in activation of kinase from heterozygous mutant lymphoma cells. J Cell Physiol (1991) 0.82